Kelly Robinson, APRN
Psychiatric/Mental Health · New Orleans, LANPI 1689933236
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,081 of the $22,807 with a category attached, or 79.3%. Teva Pharmaceuticals USA, Inc. accounts for 92.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $12,094, more than ten times the $265 reported in 2021. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $207.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$21K
- Johnson & Johnson$365
- Neurocrine Biosciences, Inc.$315
- Lundbeck LLC$231
- Alkermes, Inc.$201
- Otsuka America Pharmaceutical, Inc.$191
- plus $334 from 5 others
What the payments were for
- Speaking & faculty fees$18,08179%
- Travel & lodging$1,7278%
- Food & beverage$2,97513%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $21,170 |
| Johnson & Johnson | 13 | $365 |
| Neurocrine Biosciences, Inc. | 9 | $315 |
| Lundbeck LLC | 13 | $231 |
| Alkermes, Inc. | 9 | $201 |
| Otsuka America Pharmaceutical, Inc. | 5 | $191 |
| E.r. Squibb & Sons, L.L.C. | 3 | $155 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| AbbVie | 1 | $15 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$20,163
- CAPLYTA$125
- COBENFY$123
- ABILIFY ASIMTUFII$122
- ABILIFY MAINTENA$122
- INGREZZA$118
- INVEGA SUSTENNA$107
How this compares
$22,807 in reported general payments places this provider in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 24 | $70,787 |
| Invega SustennaPaliperidone Palmitate | 21 | $56,698 |
| Duloxetine Hcl | 26 | $940 |
| Oxcarbazepine | 13 | $925 |
| Trazodone Hcl | 38 | $684 |
| Olanzapine | 29 | $490 |
| Quetiapine Fumarate | 46 | $419 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $367 |
| Divalproex Sodium | 11 | $302 |
| Memantine Hcl | 24 | $187 |
| Risperidone | 15 | $153 |
| Gabapentin | 13 | $136 |
| Sertraline Hcl | 20 | $132 |
| Zolpidem Tartrate | 24 | $115 |
| Lisinopril | 21 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $191 | $70,78724 claims |
| Johnson & JohnsonInvega Sustenna | $365 | $56,69821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in New Orleans
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.